Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.67 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.53 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.51 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.48 |
| ▸ | EP300 | Q09472 | 3/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24221655 | 0.91 | SLC2A1 (0.78) | SLC2A1PRMT5WDR77CHRM1HSD17B2 | |
| SCHEMBL31397622 | 0.81 | SLC2A1 (0.98) | SLC2A1PRMT5WDR77CHRM1EP300 | |
| Hydrochloric Acid SCHEMBL31397599 | 0.81 | SLC2A1 (1.00) | SLC2A1PRMT5WDR77CHRM1EP300 | |
| SCHEMBL27331749 | 0.72 | HPGD (0.53) | HSD17B2 | |
| SCHEMBL31073648 | 0.71 | KDM4E (0.52) | HSD17B2POLB | |
| SCHEMBL31073650 | 0.71 | KDM4E (0.52) | HSD17B2POLB | |
| SCHEMBL31507093 | 0.70 | PRMT5 (0.70) | SLC2A1PRMT5WDR77CHRM2POLB | |
| SCHEMBL805123 | 0.69 | HSD17B2 (0.52) | HSD17B2 | |
| SCHEMBL8271475 | 0.68 | SLC6A4 (0.67) | PRMT5WDR77 | |
| SCHEMBL27327673 | 0.68 | HSD17B2 (0.50) | HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220023270-A1 | ANTIBACTERIAL COMPOUNDS AND USES THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220023270-A1 | ANTIBACTERIAL COMPOUNDS AND USES THEREOF | CLPP, SPOUT1, MRPL21 | SLC2A1 4358/4885PRMT5 3580/4885WDR77 3251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.